Role of the recombinant protein of the platelet receptor for type I collagen in the release of nitric oxide during platelet aggregation

Thromb Res. 2000 Dec 1;100(5):427-32. doi: 10.1016/s0049-3848(00)00340-6.

Abstract

Nitric oxide plays an important role in platelet function and platelets possess the endothelial isoform of nitric oxide synthase. Several reports have indicated that nitric oxide is released upon exposure of platelets to collagen. We have reported that a non-integrin platelet protein of 65 kDa is a receptor for type I collagen. By direct measurement of NO release from washed human platelets suspended in Tyrode buffer with a ISO-NO Mark II, World Precision Instruments, Sarasota, FL, USA, p30 sensor, type I collagen, but not ADP and epinephrine, induces the release of NO in a time-dependent manner. The production of NO is inhibited either by preincubation of type I collagen with the platelet type I collagen receptor recombinant protein or by preincubation of platelets with the antibody to the receptor protein, the anti-65 antibody. However, preincubation of platelets with anti-P-selectin and anti-glycoprotein IIb/IIIa did not affect the release of NO by platelets. These results suggest that the 65 kDa platelet receptor for type I collagen is specifically linked to the generation of NO, and that the 65 kDa platelet receptor for type I collagen plays an important new role in platelet function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blood Platelets / physiology*
  • Collagen / physiology
  • Humans
  • Integrins / physiology*
  • Nitric Oxide / physiology*
  • Platelet Aggregation / physiology*
  • Receptors, Collagen
  • Recombinant Proteins / metabolism
  • Signal Transduction

Substances

  • Integrins
  • Receptors, Collagen
  • Recombinant Proteins
  • Nitric Oxide
  • Collagen